Shareholding disclosure

Basilea Pharmaceutica AG

Declared position

20.13%

Threshold

Crossed downwards

Timeline

Published

30.07.2010

Transaction

26.11.2009

Voting rights breakdown

Voting rights acquired0%

Voting rights sold20.13%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAA7S00066

Beneficial owner

Basilea Pharmaceutica AG

Declared address

Basilea Pharmaceutica AG, 4005 Basel

Einräumung von Erwerbsrechten bestehend aus Mitarbeiteroptionen (gemäss dem Optionsplan der Gesellschaft), die zum Bezug von Namenaktien der Basilea Pharmaceutica AG (Basiswert) berechtigen (Bezugsverhältnis 1:1).

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Basilea Pharmaceutica AG

Basilea Pharmaceutica AG, Allschwil30.07.2010TAA7S00066

Disclosure summary

Basilea Pharmaceutica AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil on the disposal side, published by SIX Exchange Regulation on 30.07.2010, at 20.13% of voting rights. Notice category: Single shareholder.

Disclosed position

20.13%

Voting rights sold

Voting rights acquired0%

Voting rights sold20.13%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Basilea Pharmaceutica AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil, published on 30.07.2010.

Publication date30.07.2010

Transaction date26.11.2009

Issuing companyBasilea Pharmaceutica AG, Allschwil

Beneficial ownerBasilea Pharmaceutica AG

Declared addressBasilea Pharmaceutica AG, 4005 Basel

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold20.13%

Below threshold0%

ExchangeXSWX

Notification IDTAA7S00066

Commercial register

CHE-101.175.068

Registered

Zefix record

Conditions

Einräumung von Erwerbsrechten bestehend aus Mitarbeiteroptionen (gemäss dem Optionsplan der Gesellschaft), die zum Bezug von Namenaktien der Basilea Pharmaceutica AG (Basiswert) berechtigen (Bezugsverhältnis 1:1).

Source: SIX Exchange Regulation · Publication date: 30.07.2010

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open